Inactivated Polio And Rabies Vaccines Market, by Vaccine, By Method of Inactivation, By Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

A vaccine consisting of inactivated poliovirus (IPV) types 1, 2, and 3, with active immunizing activity against poliomyelitis. Upon intramuscular vaccination, inactivated poliovirus vaccine (IPV) activates the immune system to develop antibodies against polio viruses. The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for some time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. Governments around the world are actively working towards eradicating polio, which has led to increased demand for IPV. Additionally, the rising prevalence of polio in certain regions, such as the North America region, has also contributed to the growth of this segment. The increasing prevalence of polio and rabies diseases is driving the growth of the inactivated polio and the rabies vaccine associated with the virus is expected to boost the global inactivated polio and rabies vaccine market growth.

Market Dynamics

Research and development activity by market players is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. For Instance, in March 2021, Ocugen Inc., is a biotech company in the U.S., announced positive top-line data for rabies, polio and COVID-19 Vaccine. Investigational vaccine that uses the same vero cell manufacturing platform that had been used in the production of polio vaccines for decades.

Key features of the study:

This report provides an in-depth analysis of the global inactivated polio and rabies vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global inactivated polio and rabies vaccines market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., Pfizer Inc, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd ,Zoetis Inc., Elanco.,Boehringer Ingelheim International GmbH,Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd and Medimmune LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Inactivated Polio And Rabies Vaccines Market

Detailed Segmentation:

Global Inactivated Polio And Rabies Vaccines Market, By Product Type:
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
Global Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation:
- Radiation Method
- Heat Inactivation
- Solvent Detergent Method
- pH Concentration
- Health Activation
- Others
Global Inactivated Polio And Rabies Vaccines Market, By Age Group:
- Pediatrics
- Adults
Global Inactivated Polio And Rabies Vaccines Market, By Distribution Channel:
- Government
- Private
Global Inactivated Polio And Rabies Vaccines Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Bharat Biotech.Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BIO-MED
- Serum Institute of India Pvt. Ltd.
- Kedrion Biopharma Inc.
- GlaxoSmithKline plc..
- Bilthoven Biologicals.
- Merck & Co.
- Pfizer Inc.
- Cadila Healthcare Limited
- Sanofi Pasteur India Pvt Ltd
- Chiron Behring Vaccines Private Ltd
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd
- Wyeth pharmaceuticals
- Berna Biotech Ltd.
- Novartis Vaccines Ltd
- Medimmune LLC.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3581

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Method of Activation
- Market Snapshot, By Age Group
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Inactivated Polio and Rabies Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Inactivated Polio and Rabies Vaccines Market, By Product Type, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Inactivated Polio Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Inactivated Rabies Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Inactivated Polio and Rabies Vaccines Market, By Method of Inactivation, 2018 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Solvent Detergent Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Radiation Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
pH Concentration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Heat Inactivation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

7. Global Inactivated Polio and Rabies Vaccines Market, By Age Group, 2018 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

8. Global Inactivated Polio and Rabies Vaccines Market, By Distribution Channel, 2018 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

9. Global Inactivated Polio and Rabies Market, By Region, 2018 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
North America
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
U.S.
Canada
Europe
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Vaccine, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2018 - 2030 (US$ Mn)
North Africa
Central Africa
South Africa

10. Company Profiles

Bharat Biotech
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
BIO-MED
Serum Institute of India Pvt. Ltd.
Kedrion Biopharma Inc.
GlaxoSmithKline plc.
Bilthoven Biologicals
Merck & Co., Inc.
Pfizer Inc.
Cadila Healthcare Limited
Sanofi Pasteur India Pvt Ltd
Chiron Behring Vaccines Private Ltd
Zoetis Inc.
Elanco.
Boehringer Ingelheim International GmbH
Indian Immunologicals Ltd
Wyeth pharmaceuticals
Berna Biotech Ltd.
Novartis Vaccines Ltd
Medimmune LLC

11. Section

References
Research Methodology
About us and Sales Contact

Browse 36 market data tables and 32 figures on "Global Inactivated Polio And Rabies Vaccines Market " - Global Forecast to 2030

Inactivated Polio And Rabies Vaccines Market, by Vaccine, By Method of Inactivation, By Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030